Filing Analysis
📄 Other SEC Filing
Filed May 20, 2026
⚪ LOW
ProMIS Neurosciences Inc. held its 2026 Annual Meeting of Stockholders on May 20, 2026, where shareholders approved an amendment to the 2025 Stock Option and Incentive Plan to increase the share reserve by 900,000 shares. Shareholders also elected seven directors and ratified Baker Tilly US, LLP as the independent auditor for fiscal year 2026.
🚩 Red Flags
- Potential dilution from the 900,000 share increase to the 2025 Stock Option and Incentive Plan, which represents approximately 10% of the company's 8,967,693 outstanding shares.
📋 Key Facts
- The Annual Meeting of Stockholders was held on May 20, 2026, with 53.1% of the 8,967,693 outstanding shares represented.
- Shareholders approved an amendment to the 2025 Stock Option and Incentive Plan, increasing the shares available for issuance by 900,000.
- Seven director nominees (Eugene Williams, Neil Cashman, Joshua Mandel-Brehm, Maggie Shafmaster, Neil K. Warma, William Wyman, and Slanix Alex) were elected to serve until the 2027 annual meeting.
- Baker Tilly US, LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
📢 Regulation FD Disclosure
Filed May 12, 2026
⚪ LOW
ProMIS Neurosciences Inc. reported its financial results for the first quarter ended March 31, 2026. The disclosure was made through a press release furnished as an exhibit to the 8-K filing.
📋 Key Facts
- The company reported financial results for the quarter ended March 31, 2026.
- The press release was issued on May 12, 2026.
- The report was filed under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits).
📢 Regulation FD Disclosure
Filed Mar 25, 2026
⚪ LOW
ProMIS Neurosciences Inc. reported its financial results for the fiscal year ended December 31, 2025. The announcement was made via a press release furnished with the SEC on March 25, 2026.
📋 Key Facts
- The filing reports financial condition and results for the full year ended December 31, 2025.
- The information was disclosed under Item 2.02 (Results of Operations and Financial Condition).
- The press release was issued on March 25, 2026, and is included as Exhibit 99.1.
- The company is an emerging growth company listed on the Nasdaq Capital Market under the symbol PMN.
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.